Local Institution

Zielona Góra 65-046

0 studies enrolling now · 5 studies all time

What they study most

Acute Coronary Syndrome, Acute Coronary Syndrome (ACS), Diabetes Mellitus II, Hepatitis C Virus (HCV), Pulmonary Embolism, Venous Thrombosis

Studies at this site

• Phase III Acute Coronary Syndrome — Stopped early
• Safety Study of Apixaban in Recent Acute Coronary Syndrome — Completed
• Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness — Completed
• Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C — Withdrawn before enrolling
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed